Ajanta Pharma Limited — Others, 04-02-2025: Rumour Verification - Regulation 30(11)

Ajanta Pharma Limited has noted a material price movement in its share price, attributed to research reports released by brokerage houses following the company's recent quarterly results. There were no specific events or announcements that could explain this price shift, indicating that it may be driven purely by market dynamics. This update suggests that investor sentiment could be influenced by analytical coverage, potentially impacting trading activity. While the company remains detached from these fluctuations, shareholders should remain cautious and observant of how market perceptions evolve in light of ongoing evaluations.